Plus Therapeutics
PSTV
PSTV was delisted on the 31st of July, 2026.
9 hedge funds and large institutions have $981K invested in Plus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.02% less ownership
Funds ownership: 0.48% → 0.46% (-0.02%)
2% less capital invested
Capital invested by funds: $1M → $981K (-$21.4K)
18% less funds holding
Funds holding: 11 → 9 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ATPW
Ashton Thomas Private Wealth
Scottsdale,
Arizona
|
+$19.1K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$26.9K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$12.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.7K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$750 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $819K | -$12.3K | -311 | -1% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $79.2K | +$12K | +305 | +16% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $47.5K | – | – | – |
|
|
ATPW
4
Ashton Thomas Private Wealth
Scottsdale,
Arizona
| $18.9K | +$19.1K | +484 | +1,467% |
|
5
BlackRock
New York
| $10.2K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $5.42K | -$750 | -19 | -11% |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $194 | – | – | – |
|
8
JP Morgan Chase
New York
| $146 | – | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $70 | – | – | – |
|
|
DB
10
Danske Bank
Copenhagen K,
Denmark
| $1 | – | – | – |
|
11
Group One Trading
Chicago,
Illinois
| $1 | – | – | – |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$26.9K | -731 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$4.7K | -128 | Closed |
|
PSTV Hedge Fund Activity: Q3 2024 in Review
9 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q3 2024, worth a combined $981K — down 2.1% from $1M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PSTV and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Ashton Thomas Private Wealth, adding an estimated $19.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $26.9K sold.
- 9 institutional investors held Plus Therapeutics (PSTV) as of Q3 2024, down from 11 in Q2 2024.
- Funds reported $981K of Plus Therapeutics stock for Q3 2024, down 2.1% quarter-over-quarter.
- 0 funds opened new Plus Therapeutics positions in Q3 2024 and 2 closed out, a net change of -2 holders.
- The largest Plus Therapeutics buyer in Q3 2024 was Ashton Thomas Private Wealth, an estimated $19.1K added.
- The largest Plus Therapeutics seller in Q3 2024 was Citadel Advisors, an estimated $26.9K sold.
Based on aggregated 13F filings for Q3 2024.